Loading…

Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo

Abstract Nanotechnology, though not a new concept, has gained importance in medical breakthroughs. The preparation of nanosystems like polymeric nanoparticles can be used for drug and gene delivery. In this study dendrimeric nanoparticles prepared with generations 4 and 5 (G4, G5) polyamidoamine (PA...

Full description

Saved in:
Bibliographic Details
Published in:Nanomedicine 2009-09, Vol.5 (3), p.287-297
Main Authors: Navarro, Gemma, PhD, Tros de ILarduya, Conchita, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c507t-bd9f1a69b12cb0c27220868238d04b7c9e98f352744a9a7fdfa20a53fa97e4753
cites cdi_FETCH-LOGICAL-c507t-bd9f1a69b12cb0c27220868238d04b7c9e98f352744a9a7fdfa20a53fa97e4753
container_end_page 297
container_issue 3
container_start_page 287
container_title Nanomedicine
container_volume 5
creator Navarro, Gemma, PhD
Tros de ILarduya, Conchita, PhD
description Abstract Nanotechnology, though not a new concept, has gained importance in medical breakthroughs. The preparation of nanosystems like polymeric nanoparticles can be used for drug and gene delivery. In this study dendrimeric nanoparticles prepared with generations 4 and 5 (G4, G5) polyamidoamine (PAMAM) dendrimers and plasmid DNA were characterized and their ability to transfect cells in vitro and in vivo evaluated. Additionally, the efficacy of these dendrimers on activation after heat treatment has been tested to attempt an enhancement in transfection activity over that of intact dendrimers. Measurements of the particle size and zeta potential as a function of the charge ratio and the generation of the polymer reveal that no significant differences were obtained in size by using G4 or G5 polymers in nonactivated dendriplexes prepared at different charge ratios. The zeta potentials of the dendriplexes are strongly positive and differ only slightly. Atomic force microscopy images of complexes showed that they are spherical, individualized, and homogeneously distributed. These vectors were also highly effective in protecting DNA from attack by DNase I and increased the efficiency of plasmid-mediated gene transfer in vitro to liver (HepG2) and colon (CT26) cancer cells as compared with naked DNA, even in the presence of 60% fetal bovine serum. Expression is enhanced at higher charge ratios with maximal values obtained at a charge ratio of 10:1 (+/–) and by increasing the dendrimer generation. Finally, the transfection activity of G4 and G5 dendriplexes was significantly enhanced in HepG2 and CT26 cells by activation of the dendrimers. In this respect we have optimized the time of activation to obtain the optimal levels of gene expression. Also, intravenously administered activated G4 and G5 dendrimer–DNA complexes are superior to the nonactivated ones in terms of gene transfer efficiency in vivo. In conclusion, our results showed that G4 and G5 PAMAM dendrimers are an effective nanosystem for gene delivery to colon and liver cancer cells in vitro, as well as for in vivo therapeutic applications. From the Clinical Editor This paper describes the synthesis and potential applications of mixed nanoparticles prepared with generations 4 and 5 (G4, G5) poly(amidoamine) (PAMAM) dendrimers and plasmid DNA. These mixed nanoparticles proved to be effective for gene delivery to colon and liver cancer cells in vitro, as well as in vivo.
doi_str_mv 10.1016/j.nano.2008.12.007
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21094596</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1549963409000094</els_id><sourcerecordid>21094596</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-bd9f1a69b12cb0c27220868238d04b7c9e98f352744a9a7fdfa20a53fa97e4753</originalsourceid><addsrcrecordid>eNp9kUtr3DAUhUVpaNJp_0AXxavu7F49PLKgFIaQPiAhgbRrIUvXRVOPlEoew_z7yJkhhS6qjaTLOQfOdwl5R6GhQNcft00wITYMoGsoawDkC3JBW6FqtRbs5fObi3PyOuctAJcA6hU5p6plXHB6Qe43dvKzmdBVJrgqxFCb58nd5mZzUzkMLvkdplwNMVW_MGCZjX7GdKh8qGY_pfjkfvrM8Q05G8yY8e3pXpGfX65-XH6rr2-_fr_cXNe2BTnVvVMDNWvVU2Z7sEwyBt26Y7xzIHppFapu4C2TQhhl5OAGw8C0fDBKopAtX5EPx9yHFP_sMU9657PFcTQB4z5rRkGJtvRfEXYU2hRzTjjoh1LIpIOmoBeUeqsXlHpBqSnTBWUxvT-l7_sdur-WE7si-HQUYOk4e0w6W4_BovMJ7aRd9P_P__yP3Y4-eGvG33jAvI37FAo9TXUuBn2_LHPZJSgoRwn-CK6qmRo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21094596</pqid></control><display><type>article</type><title>Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo</title><source>Elsevier</source><creator>Navarro, Gemma, PhD ; Tros de ILarduya, Conchita, PhD</creator><creatorcontrib>Navarro, Gemma, PhD ; Tros de ILarduya, Conchita, PhD</creatorcontrib><description>Abstract Nanotechnology, though not a new concept, has gained importance in medical breakthroughs. The preparation of nanosystems like polymeric nanoparticles can be used for drug and gene delivery. In this study dendrimeric nanoparticles prepared with generations 4 and 5 (G4, G5) polyamidoamine (PAMAM) dendrimers and plasmid DNA were characterized and their ability to transfect cells in vitro and in vivo evaluated. Additionally, the efficacy of these dendrimers on activation after heat treatment has been tested to attempt an enhancement in transfection activity over that of intact dendrimers. Measurements of the particle size and zeta potential as a function of the charge ratio and the generation of the polymer reveal that no significant differences were obtained in size by using G4 or G5 polymers in nonactivated dendriplexes prepared at different charge ratios. The zeta potentials of the dendriplexes are strongly positive and differ only slightly. Atomic force microscopy images of complexes showed that they are spherical, individualized, and homogeneously distributed. These vectors were also highly effective in protecting DNA from attack by DNase I and increased the efficiency of plasmid-mediated gene transfer in vitro to liver (HepG2) and colon (CT26) cancer cells as compared with naked DNA, even in the presence of 60% fetal bovine serum. Expression is enhanced at higher charge ratios with maximal values obtained at a charge ratio of 10:1 (+/–) and by increasing the dendrimer generation. Finally, the transfection activity of G4 and G5 dendriplexes was significantly enhanced in HepG2 and CT26 cells by activation of the dendrimers. In this respect we have optimized the time of activation to obtain the optimal levels of gene expression. Also, intravenously administered activated G4 and G5 dendrimer–DNA complexes are superior to the nonactivated ones in terms of gene transfer efficiency in vivo. In conclusion, our results showed that G4 and G5 PAMAM dendrimers are an effective nanosystem for gene delivery to colon and liver cancer cells in vitro, as well as for in vivo therapeutic applications. From the Clinical Editor This paper describes the synthesis and potential applications of mixed nanoparticles prepared with generations 4 and 5 (G4, G5) poly(amidoamine) (PAMAM) dendrimers and plasmid DNA. These mixed nanoparticles proved to be effective for gene delivery to colon and liver cancer cells in vitro, as well as in vivo.</description><identifier>ISSN: 1549-9634</identifier><identifier>EISSN: 1549-9642</identifier><identifier>DOI: 10.1016/j.nano.2008.12.007</identifier><identifier>PMID: 19523431</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cationic polymers ; Cell Death - drug effects ; Cell Line, Tumor ; Cell Survival - drug effects ; Dendrimers ; Dendriplexes ; Deoxyribonuclease I - metabolism ; DNA - chemistry ; Electrophoretic Mobility Shift Assay ; Female ; Gene delivery ; Gene Expression - drug effects ; Gene Transfer Techniques ; Hot Temperature ; Humans ; Injections, Intravenous ; Internal Medicine ; Mice ; Mice, Inbred BALB C ; Microscopy, Atomic Force ; Nanoparticles ; Particle Size ; Polyamidoamine (PAMAM) dendrimers ; Polyamines - administration &amp; dosage ; Polyamines - chemistry ; Polyamines - pharmacology ; Surface Properties - drug effects ; Time Factors ; Transfection</subject><ispartof>Nanomedicine, 2009-09, Vol.5 (3), p.287-297</ispartof><rights>Elsevier Inc.</rights><rights>2009 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-bd9f1a69b12cb0c27220868238d04b7c9e98f352744a9a7fdfa20a53fa97e4753</citedby><cites>FETCH-LOGICAL-c507t-bd9f1a69b12cb0c27220868238d04b7c9e98f352744a9a7fdfa20a53fa97e4753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19523431$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Navarro, Gemma, PhD</creatorcontrib><creatorcontrib>Tros de ILarduya, Conchita, PhD</creatorcontrib><title>Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo</title><title>Nanomedicine</title><addtitle>Nanomedicine</addtitle><description>Abstract Nanotechnology, though not a new concept, has gained importance in medical breakthroughs. The preparation of nanosystems like polymeric nanoparticles can be used for drug and gene delivery. In this study dendrimeric nanoparticles prepared with generations 4 and 5 (G4, G5) polyamidoamine (PAMAM) dendrimers and plasmid DNA were characterized and their ability to transfect cells in vitro and in vivo evaluated. Additionally, the efficacy of these dendrimers on activation after heat treatment has been tested to attempt an enhancement in transfection activity over that of intact dendrimers. Measurements of the particle size and zeta potential as a function of the charge ratio and the generation of the polymer reveal that no significant differences were obtained in size by using G4 or G5 polymers in nonactivated dendriplexes prepared at different charge ratios. The zeta potentials of the dendriplexes are strongly positive and differ only slightly. Atomic force microscopy images of complexes showed that they are spherical, individualized, and homogeneously distributed. These vectors were also highly effective in protecting DNA from attack by DNase I and increased the efficiency of plasmid-mediated gene transfer in vitro to liver (HepG2) and colon (CT26) cancer cells as compared with naked DNA, even in the presence of 60% fetal bovine serum. Expression is enhanced at higher charge ratios with maximal values obtained at a charge ratio of 10:1 (+/–) and by increasing the dendrimer generation. Finally, the transfection activity of G4 and G5 dendriplexes was significantly enhanced in HepG2 and CT26 cells by activation of the dendrimers. In this respect we have optimized the time of activation to obtain the optimal levels of gene expression. Also, intravenously administered activated G4 and G5 dendrimer–DNA complexes are superior to the nonactivated ones in terms of gene transfer efficiency in vivo. In conclusion, our results showed that G4 and G5 PAMAM dendrimers are an effective nanosystem for gene delivery to colon and liver cancer cells in vitro, as well as for in vivo therapeutic applications. From the Clinical Editor This paper describes the synthesis and potential applications of mixed nanoparticles prepared with generations 4 and 5 (G4, G5) poly(amidoamine) (PAMAM) dendrimers and plasmid DNA. These mixed nanoparticles proved to be effective for gene delivery to colon and liver cancer cells in vitro, as well as in vivo.</description><subject>Animals</subject><subject>Cationic polymers</subject><subject>Cell Death - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Cell Survival - drug effects</subject><subject>Dendrimers</subject><subject>Dendriplexes</subject><subject>Deoxyribonuclease I - metabolism</subject><subject>DNA - chemistry</subject><subject>Electrophoretic Mobility Shift Assay</subject><subject>Female</subject><subject>Gene delivery</subject><subject>Gene Expression - drug effects</subject><subject>Gene Transfer Techniques</subject><subject>Hot Temperature</subject><subject>Humans</subject><subject>Injections, Intravenous</subject><subject>Internal Medicine</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Microscopy, Atomic Force</subject><subject>Nanoparticles</subject><subject>Particle Size</subject><subject>Polyamidoamine (PAMAM) dendrimers</subject><subject>Polyamines - administration &amp; dosage</subject><subject>Polyamines - chemistry</subject><subject>Polyamines - pharmacology</subject><subject>Surface Properties - drug effects</subject><subject>Time Factors</subject><subject>Transfection</subject><issn>1549-9634</issn><issn>1549-9642</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kUtr3DAUhUVpaNJp_0AXxavu7F49PLKgFIaQPiAhgbRrIUvXRVOPlEoew_z7yJkhhS6qjaTLOQfOdwl5R6GhQNcft00wITYMoGsoawDkC3JBW6FqtRbs5fObi3PyOuctAJcA6hU5p6plXHB6Qe43dvKzmdBVJrgqxFCb58nd5mZzUzkMLvkdplwNMVW_MGCZjX7GdKh8qGY_pfjkfvrM8Q05G8yY8e3pXpGfX65-XH6rr2-_fr_cXNe2BTnVvVMDNWvVU2Z7sEwyBt26Y7xzIHppFapu4C2TQhhl5OAGw8C0fDBKopAtX5EPx9yHFP_sMU9657PFcTQB4z5rRkGJtvRfEXYU2hRzTjjoh1LIpIOmoBeUeqsXlHpBqSnTBWUxvT-l7_sdur-WE7si-HQUYOk4e0w6W4_BovMJ7aRd9P_P__yP3Y4-eGvG33jAvI37FAo9TXUuBn2_LHPZJSgoRwn-CK6qmRo</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Navarro, Gemma, PhD</creator><creator>Tros de ILarduya, Conchita, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20090901</creationdate><title>Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo</title><author>Navarro, Gemma, PhD ; Tros de ILarduya, Conchita, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-bd9f1a69b12cb0c27220868238d04b7c9e98f352744a9a7fdfa20a53fa97e4753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Cationic polymers</topic><topic>Cell Death - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Cell Survival - drug effects</topic><topic>Dendrimers</topic><topic>Dendriplexes</topic><topic>Deoxyribonuclease I - metabolism</topic><topic>DNA - chemistry</topic><topic>Electrophoretic Mobility Shift Assay</topic><topic>Female</topic><topic>Gene delivery</topic><topic>Gene Expression - drug effects</topic><topic>Gene Transfer Techniques</topic><topic>Hot Temperature</topic><topic>Humans</topic><topic>Injections, Intravenous</topic><topic>Internal Medicine</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Microscopy, Atomic Force</topic><topic>Nanoparticles</topic><topic>Particle Size</topic><topic>Polyamidoamine (PAMAM) dendrimers</topic><topic>Polyamines - administration &amp; dosage</topic><topic>Polyamines - chemistry</topic><topic>Polyamines - pharmacology</topic><topic>Surface Properties - drug effects</topic><topic>Time Factors</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Navarro, Gemma, PhD</creatorcontrib><creatorcontrib>Tros de ILarduya, Conchita, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Nanomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Navarro, Gemma, PhD</au><au>Tros de ILarduya, Conchita, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo</atitle><jtitle>Nanomedicine</jtitle><addtitle>Nanomedicine</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>5</volume><issue>3</issue><spage>287</spage><epage>297</epage><pages>287-297</pages><issn>1549-9634</issn><eissn>1549-9642</eissn><abstract>Abstract Nanotechnology, though not a new concept, has gained importance in medical breakthroughs. The preparation of nanosystems like polymeric nanoparticles can be used for drug and gene delivery. In this study dendrimeric nanoparticles prepared with generations 4 and 5 (G4, G5) polyamidoamine (PAMAM) dendrimers and plasmid DNA were characterized and their ability to transfect cells in vitro and in vivo evaluated. Additionally, the efficacy of these dendrimers on activation after heat treatment has been tested to attempt an enhancement in transfection activity over that of intact dendrimers. Measurements of the particle size and zeta potential as a function of the charge ratio and the generation of the polymer reveal that no significant differences were obtained in size by using G4 or G5 polymers in nonactivated dendriplexes prepared at different charge ratios. The zeta potentials of the dendriplexes are strongly positive and differ only slightly. Atomic force microscopy images of complexes showed that they are spherical, individualized, and homogeneously distributed. These vectors were also highly effective in protecting DNA from attack by DNase I and increased the efficiency of plasmid-mediated gene transfer in vitro to liver (HepG2) and colon (CT26) cancer cells as compared with naked DNA, even in the presence of 60% fetal bovine serum. Expression is enhanced at higher charge ratios with maximal values obtained at a charge ratio of 10:1 (+/–) and by increasing the dendrimer generation. Finally, the transfection activity of G4 and G5 dendriplexes was significantly enhanced in HepG2 and CT26 cells by activation of the dendrimers. In this respect we have optimized the time of activation to obtain the optimal levels of gene expression. Also, intravenously administered activated G4 and G5 dendrimer–DNA complexes are superior to the nonactivated ones in terms of gene transfer efficiency in vivo. In conclusion, our results showed that G4 and G5 PAMAM dendrimers are an effective nanosystem for gene delivery to colon and liver cancer cells in vitro, as well as for in vivo therapeutic applications. From the Clinical Editor This paper describes the synthesis and potential applications of mixed nanoparticles prepared with generations 4 and 5 (G4, G5) poly(amidoamine) (PAMAM) dendrimers and plasmid DNA. These mixed nanoparticles proved to be effective for gene delivery to colon and liver cancer cells in vitro, as well as in vivo.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>19523431</pmid><doi>10.1016/j.nano.2008.12.007</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1549-9634
ispartof Nanomedicine, 2009-09, Vol.5 (3), p.287-297
issn 1549-9634
1549-9642
language eng
recordid cdi_proquest_miscellaneous_21094596
source Elsevier
subjects Animals
Cationic polymers
Cell Death - drug effects
Cell Line, Tumor
Cell Survival - drug effects
Dendrimers
Dendriplexes
Deoxyribonuclease I - metabolism
DNA - chemistry
Electrophoretic Mobility Shift Assay
Female
Gene delivery
Gene Expression - drug effects
Gene Transfer Techniques
Hot Temperature
Humans
Injections, Intravenous
Internal Medicine
Mice
Mice, Inbred BALB C
Microscopy, Atomic Force
Nanoparticles
Particle Size
Polyamidoamine (PAMAM) dendrimers
Polyamines - administration & dosage
Polyamines - chemistry
Polyamines - pharmacology
Surface Properties - drug effects
Time Factors
Transfection
title Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T19%3A22%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activated%20and%20non-activated%20PAMAM%20dendrimers%20for%20gene%20delivery%20in%20vitro%20and%20in%20vivo&rft.jtitle=Nanomedicine&rft.au=Navarro,%20Gemma,%20PhD&rft.date=2009-09-01&rft.volume=5&rft.issue=3&rft.spage=287&rft.epage=297&rft.pages=287-297&rft.issn=1549-9634&rft.eissn=1549-9642&rft_id=info:doi/10.1016/j.nano.2008.12.007&rft_dat=%3Cproquest_cross%3E21094596%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c507t-bd9f1a69b12cb0c27220868238d04b7c9e98f352744a9a7fdfa20a53fa97e4753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=21094596&rft_id=info:pmid/19523431&rfr_iscdi=true